Amylyx Pharmaceuticals, Inc. (AMLX)
28.69
-0.51
(-1.75%)
USD |
NASDAQ |
Nov 04, 14:57
Amylyx Pharmaceuticals EPS Diluted (Quarterly) : -0.3905 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3905 |
| March 31, 2026 | -0.3734 |
| December 31, 2025 | -0.3004 |
| September 30, 2025 | -0.3684 |
| June 30, 2025 | -0.4649 |
| March 31, 2025 | -0.419 |
| December 31, 2024 | -0.5474 |
| September 30, 2024 | -1.068 |
| June 30, 2024 | -1.069 |
| March 31, 2024 | -1.751 |
| December 31, 2023 | 0.0684 |
| September 30, 2023 | 0.2996 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.3147 |
| March 31, 2023 | 0.0222 |
| December 31, 2022 | -0.6528 |
| September 30, 2022 | -0.9184 |
| June 30, 2022 | -0.9237 |
| March 31, 2022 | -0.8269 |
| December 31, 2021 | -0.4898 |
| September 30, 2021 | -0.4098 |
| June 30, 2021 | -0.3788 |
| March 31, 2021 | -0.251 |
| December 31, 2020 | -0.1522 |
| September 30, 2020 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.56 |
| Eli Lilly & Co. | 7.221 |
| Merck & Co., Inc. | 2.044 |
| Bristol Myers Squibb Co. | 1.053 |
| ANI Pharmaceuticals, Inc. | 1.052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.42M |
| Total Expenses (Quarterly) | 43.42M |
| Enterprise Value | 3.006B |
| Earnings Yield | -4.99% |
| Normalized Earnings Yield | -4.994 |